Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
JP Stock MarketDetailed Quotes
2782 Seria
- 2817
- -18-0.63%
20min DelayMarket Closed Dec 30 15:30 JST
213.64BMarket Cap21.58P/E (Static)
2834High2794Low120.20KVolume2819Open2835Pre Close337.82MTurnover365552wk High0.29%Turnover Ratio75.84MShares251552wk Low144.26EPS TTM116.32BFloat Cap7390Historical High21.58P/E (Static)41.29MShs Float84Historical Low130.56EPS LYR1.41%Amplitude70.00Dividend TTM2.03P/B100Lot Size2.48%Div YieldTTM
Seria Key Stats
Quarterly+Annual
YOY
| (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7.92%58.12B | 5.11%223.2B | 9.82%56.73B | 5.51%59.34B | 2.56%53.28B | 2.56%53.85B | 2.05%212.36B | 2.64%51.66B | 3.45%56.24B | 1.08%51.95B |
| Cost of revenue | 7.89%34.17B | 6.23%131.01B | 9.03%33.11B | 6.11%34.83B | 4.32%31.4B | 5.45%31.67B | 4.67%123.33B | 6.72%30.37B | 6.72%32.82B | 3.46%30.1B |
| Gross profit | 7.96%23.94B | 3.55%92.19B | 10.94%23.62B | 4.68%24.52B | 0.12%21.88B | -1.31%22.17B | -1.36%89.03B | -2.67%21.29B | -0.81%23.42B | -2.02%21.85B |
| Operating expense | 4.91%19.96B | 4.73%77.06B | 5.54%19.75B | 4.58%19.45B | 3.64%18.83B | 5.15%19.03B | 6.13%73.58B | 6.53%18.71B | 6.21%18.6B | 6.59%18.17B |
| Staff costs | --8.2B | 4.70%32.27B | ---- | ---- | ---- | ---- | 3.32%30.82B | ---- | ---- | ---- |
| Selling and administrative expenses | --2.74B | 1.97%13.59B | ---- | ---- | ---- | ---- | 13.75%13.32B | ---- | ---- | ---- |
| -Selling and marketing expense | --238M | 2.82%948M | ---- | ---- | ---- | ---- | 4.06%922M | ---- | ---- | ---- |
| -General and administrative expense | --2.5B | 1.90%12.64B | ---- | ---- | ---- | ---- | 14.54%12.4B | ---- | ---- | ---- |
| Depreciation and amortization | --1.19B | 6.25%4.88B | ---- | ---- | ---- | ---- | 8.38%4.59B | ---- | ---- | ---- |
| -Depreciation | --1.19B | 6.25%4.88B | ---- | ---- | ---- | ---- | 8.38%4.59B | ---- | ---- | ---- |
| Rent and land expenses | --6.77B | 5.96%26.33B | ---- | ---- | ---- | ---- | 5.48%24.85B | ---- | ---- | ---- |
| Other operating expenses | --1.07B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit | 26.41%3.98B | -2.09%15.13B | 50.14%3.87B | 5.08%5.07B | -17.23%3.05B | -28.06%3.15B | -26.16%15.45B | -40.15%2.58B | -20.95%4.82B | -29.98%3.68B |
| Net non-operating interest income (expenses) | 0 | 50.00%-2M | 0 | 50.00%-1M | 0 | 0.00%-1M | 0.00%-4M | 0 | -100.00%-2M | 0.00%-1M |
| Non-operating interest income | 0.00%1M | 20.00%6M | 0.00%2M | 0.00%1M | 100.00%2M | 0.00%1M | -28.57%5M | 100.00%2M | -50.00%1M | -50.00%1M |
| Non-operating interest expense | -50.00%1M | -11.11%8M | 0.00%2M | -33.33%2M | 0.00%2M | 0.00%2M | -18.18%9M | -33.33%2M | 0.00%3M | -33.33%2M |
| Net investment income | 100.00%2M | 33.33%4M | 1M | 0.00%2M | 0 | 0.00%1M | 0.00%3M | 0 | 0.00%2M | 0 |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 78.57%-21M | -276.39%-877M | -305.23%-620M | -229.73%-122M | -2.78%-37M | -1,300.00%-98M | -8.88%-233M | -240.00%-153M | 15.91%-37M | -24.14%-36M |
| Less:Other special charges | -400.00%-9M | 165.52%19M | 171.43%15M | 122.22%2M | ---1M | --3M | -2,800.00%-29M | -1,150.00%-21M | -800.00%-9M | ---- |
| Less:Write off | -68.42%30M | 227.48%858M | 247.70%605M | 160.87%120M | 8.57%38M | 1,257.14%95M | 21.86%262M | 304.65%174M | 2.22%46M | 12.90%35M |
| Other non-operating income (expenses) | -62.71%22M | 47.55%211M | -41.89%43M | 177.14%97M | -7.69%12M | 180.95%59M | -66.51%143M | -52.56%74M | -77.56%35M | -87.38%13M |
| Income before tax | 27.81%3.97B | -5.85%14.46B | 31.87%3.29B | 4.83%5.06B | -17.67%3.01B | -29.16%3.11B | -27.33%15.36B | -43.50%2.49B | -22.39%4.82B | -31.37%3.66B |
| Income tax | 24.88%1.3B | -9.16%4.63B | 1.92%955M | 4.97%1.63B | -15.53%1.01B | -26.53%1.04B | -25.33%5.1B | -38.03%937M | -21.18%1.55B | -29.49%1.2B |
| Net income | 29.35%2.67B | -4.20%9.82B | 49.97%2.33B | 4.76%3.43B | -18.68%2B | -30.45%2.07B | -28.30%10.25B | -46.39%1.55B | -22.92%3.28B | -32.30%2.46B |
| Net income continuous operations | 29.28%2.67B | -4.20%9.82B | 49.94%2.33B | 4.76%3.43B | -18.71%2B | -30.41%2.07B | -28.29%10.26B | -46.36%1.55B | -22.95%3.27B | -32.25%2.46B |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 29.35%2.67B | -4.20%9.82B | 49.97%2.33B | 4.76%3.43B | -18.68%2B | -30.45%2.07B | -28.30%10.25B | -46.39%1.55B | -22.92%3.28B | -32.30%2.46B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 29.35%2.67B | -4.20%9.82B | 49.97%2.33B | 4.76%3.43B | -18.68%2B | -30.45%2.07B | -28.30%10.25B | -46.39%1.55B | -22.92%3.28B | -32.30%2.46B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 29.33%35.5 | -4.20%130.56 | 49.93%30.96 | 4.78%45.6 | -18.71%26.55 | -30.44%27.45 | -27.79%136.29 | -46.17%20.65 | -22.33%43.52 | -31.73%32.66 |
| Diluted earnings per share | 29.33%35.5 | -4.20%130.56 | 49.97%30.9545 | 4.78%45.6 | -18.70%26.55 | -30.44%27.45 | -27.79%136.29 | -46.19%20.6407 | -22.32%43.52 | -31.74%32.6557 |
| Dividend per share | 0 | 0.00%70 | 0.00%35 | 0 | 0.00%35 | 0 | 0.00%70 | 0.00%35 | 0 | 0.00%35 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |